| Gene Set | Leading Edge Genes |
|---|---|
| DIAZ CHRONIC MEYLOGENOUS LEUKEMIA UP | FKBP5, ABI1, POLE3, HMGCR, TRAK2, DNM1L, STK24, SLBP, SH3BGRL, AASDHPPT, DEK, CREG1, BTBD1, ABCD3, DDX1, VCL, MAN2A1, GSR, AZIN1, HS2ST1, GMCL1, RTN4, SEPT2, YME1L1, CPSF6, CCDC6, AGL, IL1RAP, GEMIN4, DCTN4, SCP2, LMAN1, SEC63, PIK3CB, KHDRBS1, HMG20A, PRKRA, ALDH6A1, ATF2, LIN7C, MATN2, TUBGCP3, RAD1, PRKRIR, GART, TIMM17A, SMC2, NCBP2, SS18, SPTLC1, SMARCC2, CDC42BPA, TAF2, SEC23IP, WRB, CBFB, OXSR1, ACVR1, IPO7, F2R, BAG4, DYRK1A, PDHB, EXOC5, PAICS, SCARB2, UBE2B, ACADM, COIL, FHL2, WSB2, EIF2B1, BNIP2, UBE2E3, DNAJA2, ABCE1, ILF2, PRKAR1A, BRCA1, TCF12, B3GALNT1, HSPG2, SERPINE2, MAP4K5, C1D, NPTN, PMPCB, TMOD3, KYNU, PPP2R1B, STAT3, CNIH, PPP2R5C, UBE4B, STAG2, CTCF, CD2AP, USP22, ARL5A, AMD1, RANBP9, AGPS, RAP2C, API5, GMNN, HP1BP3, PDCD10, GTF2A2, AKAP1, USP1, TWSG1, RNF6, ATP2C1, PPP1R7, ATG12, TM2D1, PTPRA, SEC31A, WRN, IVD, PDLIM5, RPS6KA3, ATP6V1A, CAB39, VPS4B, AHCYL1, STAU2, MSH2, SNAP23, SSR1, TPM1, GTF3C3, SMARCA2, ACTR2, SGPP1, PSIP1, PCNP, ZMPSTE24, HAT1, F11R, QDPR |
| NUYTTEN NIPP1 TARGETS DN | PPP1CB, SEC23A, IL6ST, HMGCR, ASPH, TMPO, PRKAR1A, RNF138, BMPR2, SMU1, AASDHPPT, PCGF3, LPP, TSPYL1, SP3, ABCA1, NOTCH1, UGDH, VCL, GALNT7, MAN2A1, ACSL3, PKD2, RNF11, PPP2R1B, YME1L1, ROCK2, CPSF6, EPAS1, GOLT1B, PRR11, SMC1A, RANBP9, ACOX1, FBXO21, SERINC1, PDCD10, RBM12, TBL1XR1, PRPS2, FZD4, PAK2, RB1CC1, MTMR9, TSGA14, GALNT10, CAV2, TMED7, UBE2W, F2R, CAV1, RAI14, SLC25A24, CMTM6, CREBL2, FNBP1, CCND1, PIR, NF2, SGPP1, GOLGA1, ANP32E, ECT2, WSB2, RPS6KB1, TULP4, SYNJ2BP, CCDC91, ZMPSTE24 |
| WAMUNYOKOLI OVARIAN CANCER GRADES 1 2 UP | ABCD3, SAR1B, ECT2, DDAH1, GFPT1, CD164, MYO10, ITGA6, GALNT7, CASK, SEC22B, SLC35A3, F11R |
| BORCZUK MALIGNANT MESOTHELIOMA UP | UBE2D1, PAK2, SMC1A, SS18, RCOR1, CDC42BPA, SEC23IP, RPS6KA3, CALD1, WSB2, SMAD5, NEK4, MFN1, TMED7, AZIN1, FZD6, ITGAV, TNPO1, STAT3, SSR1, IPO7, F2R, RAD1 |
| BIDUS METASTASIS UP | PREPL, RRN3, NFIB, SFPQ, DCTN4, RNF138, DBF4, PAK2, MPHOSPH9, AMD1, SMC1A, STRN3, RCOR1, ECT2, WRB, CAND1, CBFB, KHDRBS1, ATP6V0A2, PTP4A1 |
| MILI PSEUDOPODIA HAPTOTAXIS UP | RNF6, PPP3CA, CLOCK, PPP1R7, LIMS1, DDX5, FNBP1L, RNF138, DNM1L, TRAPPC2, SACM1L, IFT74, TCF12, RIOK3, SH3BGRL, AASDHPPT, MAPK8, DEK, DNAJC15, VPS4B, AP4S1, BTBD1, DDX1, C1D, YTHDF3, SNAP23, ASNSD1, NAT12, YME1L1, PALLD, CPSF6, STAG2, TRIM44, CD2AP, BHLHB9, ARL5A, PPFIA1, SCP2, MTMR6, GOLPH3, ACTR2, CUL4B, PSIP1, GULP1, MBNL1, SMCHD1, PDCD10, ATF2, SYNJ2BP, PCNP, NXT2, ARMC1, CDV3, ARMCX3, ZFR |
| SENGUPTA NASOPHARYNGEAL CARCINOMA UP | |
| FLECHNER BIOPSY KIDNEY TRANSPLANT OK VS DONOR UP | |
| BOYAULT LIVER CANCER SUBCLASS G123 UP | |
| FINETTI BREAST CANCERS KINOME GRAY | |
| RAMALHO STEMNESS UP | |
| GENTILE RESPONSE CLUSTER D3 | |
| GEORGES CELL CYCLE MIR192 TARGETS | |
| GINESTIER BREAST CANCER ZNF217 AMPLIFIED UP | |
| SEIDEN ONCOGENESIS BY MET | |
| MILI PSEUDOPODIA CHEMOTAXIS UP | |
| NIKOLSKY BREAST CANCER 6P24 P22 AMPLICON | |
| REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | |
| GARY CD5 TARGETS DN | |
| VANHARANTA UTERINE FIBROID WITH 7Q DELETION UP | |
| ENK UV RESPONSE KERATINOCYTE DN | |
| LINDGREN BLADDER CANCER WITH LOH IN CHR9Q | |
| ZHANG BREAST CANCER PROGENITORS UP | |
| RODRIGUES THYROID CARCINOMA POORLY DIFFERENTIATED DN | |
| SIMBULAN UV RESPONSE IMMORTALIZED DN | |
| ZHANG RESPONSE TO IKK INHIBITOR AND TNF DN | |
| SPIELMAN LYMPHOBLAST EUROPEAN VS ASIAN DN | |
| SESTO RESPONSE TO UV C2 | |
| RODRIGUES THYROID CARCINOMA POORLY DIFFERENTIATED UP | |
| PUIFFE INVASION INHIBITED BY ASCITES DN | |
| HAMAI APOPTOSIS VIA TRAIL UP | |
| MAYBURD RESPONSE TO L663536 DN | |
| KINSEY TARGETS OF EWSR1 FLII FUSION UP | |
| OSMAN BLADDER CANCER UP | |
| WEI MYCN TARGETS WITH E BOX | |
| TIEN INTESTINE PROBIOTICS 2HR DN | |
| WANG LMO4 TARGETS DN | |
| DE YY1 TARGETS DN | |
| PYEON HPV POSITIVE TUMORS UP | |
| MOREAUX MULTIPLE MYELOMA BY TACI DN | |
| JI RESPONSE TO FSH DN | |
| SCHLOSSER MYC TARGETS REPRESSED BY SERUM | |
| MARTINEZ RESPONSE TO TRABECTEDIN DN | |
| SCHLOSSER SERUM RESPONSE DN | |
| WENDT COHESIN TARGETS UP | |
| PYEON CANCER HEAD AND NECK VS CERVICAL UP | |
| SCHLOSSER MYC TARGETS AND SERUM RESPONSE DN | |
| AMIT SERUM RESPONSE 240 MCF10A | |
| GEORGES TARGETS OF MIR192 AND MIR215 | |
| DODD NASOPHARYNGEAL CARCINOMA DN |
| Color legend | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| q-value | -1 | -0.2 | -0.05 | -0.01 | -0.001 | -0.0001 | |||||
| Color | |||||||||||
| fusobacterium nucleatum | streptococcus pneumoniae d39 | helicobacter pylori kx1 npgec | GeneSet Name |
|---|---|---|---|
| -0.14615 | -0.01910 | -0.00276 | DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_UP |
| -0.07083 | -0.10034 | -0.00278 | NUYTTEN_NIPP1_TARGETS_DN |
| -0.15502 | -0.02691 | -0.00277 | WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_UP |
| -0.18480 | -0.01909 | -0.00038 | BORCZUK_MALIGNANT_MESOTHELIOMA_UP |
| -0.13324 | -0.00363 | -0.00728 | BIDUS_METASTASIS_UP |
| -0.00094 | -0.00055 | -0.00566 | MILI_PSEUDOPODIA_HAPTOTAXIS_UP |
| -0.17776 | -0.01952 | -0.06471 | SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP |
| -0.07498 | -0.02677 | -0.01154 | FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP |
| -0.09954 | -0.06172 | -0.10257 | BOYAULT_LIVER_CANCER_SUBCLASS_G123_UP |
| -0.00509 | -0.00445 | -0.18356 | FINETTI_BREAST_CANCERS_KINOME_GRAY |
| -0.02882 | -0.02514 | -0.01531 | RAMALHO_STEMNESS_UP |
| -0.01573 | -0.13524 | -0.09658 | GENTILE_RESPONSE_CLUSTER_D3 |
| -0.02296 | -0.00050 | -0.04536 | GEORGES_CELL_CYCLE_MIR192_TARGETS |
| -0.00012 | -0.04073 | -0.03537 | GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_UP |
| -0.00148 | -0.01299 | -0.01567 | SEIDEN_ONCOGENESIS_BY_MET |
| -0.16615 | -0.15340 | -0.02015 | MILI_PSEUDOPODIA_CHEMOTAXIS_UP |
| -0.07457 | -0.00446 | -0.18865 | NIKOLSKY_BREAST_CANCER_6P24_P22_AMPLICON |
| -0.18296 | -0.18461 | -0.02227 | REACTOME_BRANCHED_CHAIN_AMINO_ACID_CATABOLISM |
| -0.00338 | -0.00609 | -0.10908 | GARY_CD5_TARGETS_DN |
| -0.04483 | -0.03959 | -0.15633 | VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_UP |
| -0.04527 | -0.00006 | -0.01138 | ENK_UV_RESPONSE_KERATINOCYTE_DN |
| -0.16506 | -0.01258 | -0.06746 | LINDGREN_BLADDER_CANCER_WITH_LOH_IN_CHR9Q |
| -0.10666 | -0.00141 | -0.01156 | ZHANG_BREAST_CANCER_PROGENITORS_UP |
| -0.13374 | -0.11167 | -0.07886 | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN |
| -0.00333 | -0.09438 | -0.01763 | SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN |
| -0.16384 | -0.00279 | -0.15312 | ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_DN |
| -0.08169 | -0.02505 | -0.01818 | SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_DN |
| -0.03586 | -0.05615 | -0.19285 | SESTO_RESPONSE_TO_UV_C2 |
| -0.03429 | -0.00145 | -0.02887 | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP |
| -0.18547 | -0.08192 | -0.06541 | PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN |
| -0.03971 | -0.00070 | -0.13654 | HAMAI_APOPTOSIS_VIA_TRAIL_UP |
| -0.09729 | -0.04824 | -0.01125 | MAYBURD_RESPONSE_TO_L663536_DN |
| -0.12235 | -0.02023 | -0.00330 | KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP |
| -0.01118 | -0.04986 | -0.06399 | OSMAN_BLADDER_CANCER_UP |
| -0.11861 | -0.09841 | -0.05065 | WEI_MYCN_TARGETS_WITH_E_BOX |
| -0.10515 | -0.01281 | -0.19693 | TIEN_INTESTINE_PROBIOTICS_2HR_DN |
| -0.16511 | -0.04096 | -0.09958 | WANG_LMO4_TARGETS_DN |
| -0.01099 | -0.05902 | -0.15325 | DE_YY1_TARGETS_DN |
| -0.03442 | -0.04095 | -0.15012 | PYEON_HPV_POSITIVE_TUMORS_UP |
| -0.07295 | -0.00101 | -0.04602 | MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN |
| -0.00157 | -0.08972 | -0.06401 | JI_RESPONSE_TO_FSH_DN |
| -0.04740 | -0.02132 | -0.08176 | SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM |
| -0.02276 | -0.04630 | -0.07984 | MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN |
| -0.19158 | -0.01883 | -0.05312 | SCHLOSSER_SERUM_RESPONSE_DN |
| -0.07494 | -0.00150 | -0.07623 | WENDT_COHESIN_TARGETS_UP |
| -0.13436 | -0.00499 | -0.10165 | PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP |
| -0.08684 | -0.12880 | -0.17846 | SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_DN |
| -0.01127 | -0.15619 | -0.15220 | AMIT_SERUM_RESPONSE_240_MCF10A |
| -0.00746 | -0.00046 | -0.02663 | GEORGES_TARGETS_OF_MIR192_AND_MIR215 |
| -0.09966 | -0.01300 | -0.06590 | DODD_NASOPHARYNGEAL_CARCINOMA_DN |